Brain Chip For Treatment-Resistant Depression Approved For Clinical Trial
The brain-chip interface aims to help the nearly 3 million people in the U.S. who live with treatment-resistant depression.
Advertisement
Researchers discovered a faster and more precise biomedical imaging technique to target brain therapies.
Routine medical records could help AI models flag risk early, when support for a child matters the most.
Researchers believe the method could also be a viable treatment for autoimmune diseases such as rheumatoid arthritis and lupus.